Skip to main content
. 2022 Sep 1;9:919069. doi: 10.3389/fmed.2022.919069

FIGURE 1.

FIGURE 1

Patient selection flow. HCC, hepatocellular carcinoma; HAIC, hepatic arterial infusion chemotherapy; PD-1, programmed cell death protein-1; TACE, transarterial chemoembolization; BCLC, Barcelona Clinic Liver Cancer.